NO974934L - 10,13,15-trioksatrisyklo£9.2.1.19.6|pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene - Google Patents

10,13,15-trioksatrisyklo£9.2.1.19.6|pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene

Info

Publication number
NO974934L
NO974934L NO974934A NO974934A NO974934L NO 974934 L NO974934 L NO 974934L NO 974934 A NO974934 A NO 974934A NO 974934 A NO974934 A NO 974934A NO 974934 L NO974934 L NO 974934L
Authority
NO
Norway
Prior art keywords
trioxatric
pentadecanone
cyclo
derivatives
compounds
Prior art date
Application number
NO974934A
Other languages
English (en)
Other versions
NO974934D0 (no
NO308362B1 (no
Inventor
Dagmar Haeltje
Ulf Preuschoff
Christian Eeckhout
Emil Finner
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of NO974934D0 publication Critical patent/NO974934D0/no
Publication of NO974934L publication Critical patent/NO974934L/no
Publication of NO308362B1 publication Critical patent/NO308362B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
NO974934A 1996-10-24 1997-10-24 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene NO308362B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19644195A DE19644195A1 (de) 1996-10-24 1996-10-24 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
NO974934D0 NO974934D0 (no) 1997-10-24
NO974934L true NO974934L (no) 1998-04-27
NO308362B1 NO308362B1 (no) 2000-09-04

Family

ID=7809858

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974934A NO308362B1 (no) 1996-10-24 1997-10-24 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene

Country Status (27)

Country Link
US (1) US5912235A (no)
EP (1) EP0838469B1 (no)
JP (1) JP4175682B2 (no)
KR (1) KR100466495B1 (no)
CN (1) CN1093133C (no)
AR (1) AR009809A1 (no)
AT (1) ATE211745T1 (no)
AU (1) AU726092B2 (no)
BR (2) BR9705143A (no)
CA (1) CA2219311C (no)
CZ (1) CZ291768B6 (no)
DE (2) DE19644195A1 (no)
DK (1) DK0838469T3 (no)
DZ (1) DZ2322A1 (no)
ES (1) ES2170318T3 (no)
HK (1) HK1010885A1 (no)
HU (1) HU222540B1 (no)
IL (1) IL121969A (no)
MX (1) MX9707974A (no)
NO (1) NO308362B1 (no)
NZ (1) NZ328979A (no)
PL (1) PL184693B1 (no)
PT (1) PT838469E (no)
RU (1) RU2181727C2 (no)
SK (1) SK283114B6 (no)
UA (1) UA44310C2 (no)
ZA (1) ZA979059B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100239A (en) * 1996-11-26 2000-08-08 Chugai Seiyaku Kabushiki Kaisha 13-membered ring macrolide compound, medicine containing the same, and process for producing the same
US6734292B1 (en) 2000-08-17 2004-05-11 The Kitasato Institute Pseudoerythromycin derivatives
JP2003007917A (ja) * 2001-06-19 2003-01-10 Sanyo Electric Co Ltd 回路装置の製造方法
US6986882B2 (en) * 2002-01-17 2006-01-17 Astrazeneca Ab Therapy for functional dyspepsia
EP1633774B1 (en) 2003-06-18 2010-02-17 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor
GB0611907D0 (en) 2006-06-15 2006-07-26 Glaxo Group Ltd Compounds
EP1902022A1 (en) 2005-07-12 2008-03-26 Glaxo Group Limited Piperazine heteroaryl derivates as gpr38 agonists
SI1907374T1 (sl) * 2005-07-26 2012-11-30 Glaxo Group Ltd Derivati benzilpiperazina uporabni za zdravljenje gastrointestinalnih motenj
NZ568763A (en) * 2005-12-08 2010-04-30 Pfizer Method for demethylating the 3'-dimethylamino group of erythromycin compounds
PE20080345A1 (es) 2006-06-28 2008-05-29 Glaxo Group Ltd Derivados de piperazina como agonistas del receptor de gpr38
EP2054429B1 (en) 2006-09-11 2013-11-06 Tranzyme Pharma, Inc. Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders
BRPI1007962A2 (pt) 2009-02-27 2016-02-23 Raqualia Pharma Inc composto de fórmula (i), composição farmacêutica contendo o mesmo, uso do mesmo ou de seu sal farmaceuticamente aceitável e método para o tratamento de uma doença mediada pela atividade agonística de receptor de motilina, em um indíviduo mamífero, incluindo um ser humano.
JP6295247B2 (ja) * 2013-03-25 2018-03-14 ゼリア新薬工業株式会社 食後期の胃運動亢進剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725385A (en) * 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
US5106961A (en) * 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
US4920102A (en) * 1988-04-18 1990-04-24 Eli Lilly And Company Method for treating gastrointestinal disorders
DE4200145A1 (de) * 1992-01-07 1993-07-08 Kali Chemie Pharma Gmbh 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
DE59705964D1 (de) 2002-02-14
HU222540B1 (hu) 2003-08-28
RU2181727C2 (ru) 2002-04-27
NO974934D0 (no) 1997-10-24
JPH10130297A (ja) 1998-05-19
DK0838469T3 (da) 2002-03-18
CA2219311C (en) 2007-09-04
HUP9701660A3 (en) 1998-08-28
HK1010885A1 (en) 1999-07-02
PL322802A1 (en) 1998-04-27
KR19980032626A (ko) 1998-07-25
IL121969A (en) 2000-06-29
DE19644195A1 (de) 1998-04-30
BR9705157A (pt) 1999-09-28
UA44310C2 (uk) 2002-02-15
DZ2322A1 (fr) 2002-12-28
NZ328979A (en) 1998-10-28
JP4175682B2 (ja) 2008-11-05
HU9701660D0 (en) 1997-12-29
CN1093133C (zh) 2002-10-23
MX9707974A (es) 1998-04-30
US5912235A (en) 1999-06-15
AU4278897A (en) 1998-04-30
ES2170318T3 (es) 2002-08-01
IL121969A0 (en) 1998-03-10
PL184693B1 (pl) 2002-12-31
KR100466495B1 (ko) 2005-05-27
HUP9701660A2 (hu) 1998-05-28
SK283114B6 (sk) 2003-02-04
NO308362B1 (no) 2000-09-04
BR9705143A (pt) 2000-12-12
CA2219311A1 (en) 1998-04-24
CZ291768B6 (cs) 2003-05-14
ATE211745T1 (de) 2002-01-15
CZ310697A3 (cs) 1998-06-17
PT838469E (pt) 2002-05-31
CN1186808A (zh) 1998-07-08
ZA979059B (en) 1998-05-07
EP0838469A1 (de) 1998-04-29
SK141997A3 (en) 1998-05-06
AU726092B2 (en) 2000-11-02
AR009809A1 (es) 2000-05-03
EP0838469B1 (de) 2002-01-09

Similar Documents

Publication Publication Date Title
DK0882024T3 (da) Forbindelser, som inhiberer retroviral protease
NL300214I1 (nl) Chinazolinederivaten.
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
HK1028344A1 (en) Resorcinol derivatives.
PT901474E (pt) Derivados de aril-pirimidina.
NO991815D0 (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
TR199800085A3 (tr) 8-Sübstitüye edilmis-1,3,8-triaza- spiro(4,5)dekan-4-on türevleri.
TR199600883A2 (tr) Pürin-6-on türevleri.
ZA200104280B (en) Pharmaceutical combination preparations.
DE59610313D1 (de) Synergistische herbizide mischungen, enthaltend cyclohexenonoximether
TR199802520A3 (tr) 1,3,8-Triaza-spiro(4,5) dekan -4-on türevleri.
NO991560D0 (no) PDE IV som inhiberer 2-cyanoiminoimidazol-derivater
DE69814441D1 (de) 6,11-verbrückte erythromycinderivate
NO974934L (no) 10,13,15-trioksatrisyklo£9.2.1.19.6|pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene
TR199600715A2 (tr) Kefalosforin türevleri.
DK1015433T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oler, fremgangsmåder til fremstilling af disse og deres anvendelse som lægemidler
NO960272L (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
NO983540L (no) Farmas°ytiske preparater inneholdende cilansetron som er stabilisert mot racemisering
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
TR199600064A2 (tr) 4-amino-benzoilguanidin-türevleri.
NO990675L (no) 11-acetyl-12,13-dioksabisyklo[8.2.1.]-tridekenonderivater, fremgangsmåter for deres fremstilling, samt legemidler inneholdende slike forbindelser
TR199601018A1 (tr) Farmasötik bilesikler.
TR28915A (tr) Naftokinon türevleri.
ZA988782B (en) Aporphinoid derivatives, processes for their production and pharmaceutical agents containing these compounds.
DE69600189D1 (de) N,N-Diethyl-8,8-dipropyl-2-azaspiro[4.5]decan-2-propan-amin Dimaleatsalz

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees